1. Lee MJ, Kwon WY, Park JS, Eo EK, Oh BJ, Lee SW, Suh JH, Roh HK. Clinical characteristics of acute pure organophosphate compounds poisoning: 38 multi-centers survey in South Korea. J Korean Soc Clin Toxicol 2007;5:27-35.
3. Harris LW, Talbot BG, Lennox WJ, Anderson DR. The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal efficacy against carbamate intoxication. Toxicol Appl Pharmacol 1989;98:128-133.
4. Merrill DG, Mihm FG. Prolonged toxicity of organophosphate poisoning. Crit Care Med 1982;10:550-551.
5. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000;12:22-37.
6. Asari Y, Kamijyo Y, Soma K. Changes in the hemodynamic state of patients with acute lethal organophosphate poisoning. Vet Hum Toxicol 2004;46:5-9.
8. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987;316:761-763.
9. Sevim S, Aktekin M, Dogu O, Ozturk H, Ertas M. Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can J Neurol Sci 2003;30:75-78.
10. Peter JV, Jerobin J, Nair A, Bennett A, Samuel P, Chrispal A, Abraham OC, Mathews KP, Fleming JJ, Oommen A. Clinical profile and outcome of patients hospitalized with dimethyl and diethyl organophosphate poisoning. Clin Toxicol (Phila) 2010;48:916-923.
11. Suh JH, Roh HK. A case of amitraz insecticide intoxication after ingestion of large amount. J Korean Soc Clin Toxicol 2008;6:52-56.
12. Oh M, Go Y. General anesthesia using atracurium for patient with acute organophosphate poisoning: a case report. Korean J Anesthesiol 2006;51:233-235.
15. Karakus A, Celik MM, Karcioglu M, Tuzcu K, Erden ES, Zeren C. Cases of organophosphate poisoning treated with high-dose of atropine in intensive care unit and the novel treatment approaches. Toxicol Ind Health 2012;09. 25. [Epub]. DOI:
10.1177/0748233712462478.
16. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med 2003;10:1303-1306.
18. Ali-Melkkila T, Kanto J, Iisalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand 1993;37:633-642.
19. Connors NJ, Harnett ZH, Hoffman RS. Comparison of current recommended regimens of atropinization in organophosphate poisoning. J Med Toxicol 2013;07. 31. [Epub]. DOI:
10.1007/s13181-013-0324-9.
20. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971;50:475-492.
21. Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med 2003;10:295-298.
24. LeBlanc FN, Benson BE, Gilg AD. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol 1986;24:69-76.
25. Borowitz SM. Prolonged organophosphate toxicity in a twenty-six-month-old child. J Pediatr 1988;112:302-304.
26. Park JH, Park YJ, Kim SP, Cho SH, Kim SJ, Cho NS. Analysis of atropine induced psychosis in substance abuse patients. J Korean Soc Emerg Med 2006;17:336-343.
27. Sidell FR, Groff WA. Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J Pharm Sci 1971;60:1224-1228.
29. Rump S, Faff J, Borkowska G, Ilczuk I, Rabsztyn T. Central therapeutic effects of dihydroderivative of pralidoxime (pro-2-PAM) in organophosphate intoxication. Arch Int Pharmacodyn Ther 1978;232:321-332.
31. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003;22:165-190.
32. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999;107:233-239.
33. Davison AN. Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. I. Diethyl p-nitrophenyl phosphate (E 600, paraoxon). Biochem J 1953;54:583-590.
35. Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier. Neurochem Res 2003;28:1401-1407.
36. Lotti M, Becker CE. Treatment of acute organophosphate poisoning: evidence of a direct effect on central nervous system by 2-PAM (pyridine-2-aldoxime methyl chloride). J Toxicol Clin Toxicol 1982;19:121-127.
37. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 2002;95:275-283.
38. Medicis JJ, Stork CM, Howland MA, Hoffman RS, Goldfrank LR. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. J Toxicol Clin Toxicol 1996;34:289-295.
39. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006;368:2136-2141.
42. Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2011;(2):CD005085.
43. Eddleston M, Eyer P, Worek F, Juszczak E, Alder N, Mohamed F, Senarathna L, Hittarage A, Azher S, Jeganathan K, Jayamanne S, von Meyer L, Dawson AH, Sheriff MH, Buckley NA. Pralidoxime in acute organophosphorus insecticide poisoning: a randomised controlled trial. PLoS Med 2009;6:e1000104.
44. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005;366:1452-1459.
45. Chang P, Ganendran A. Pressor action of pyridine-2-aldoxime in malathion poisoning. Clin Exp Pharmacol Physiol 1978;5:125-130.
46. Kozak RJ, Siegel S, Kuzma J. Rapid atropine synthesis for the treatment of massive nerve agent exposure. Ann Emerg Med 2003;41:685-688.